- TCRT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Alaunos Therapeutics (TCRT) 10-K/A2017 FY Annual report (amended)
Filed: 30 Apr 18, 12:00am
Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
I, Kevin G. Lafond, certify that:
1. | I have reviewed this Amendment No. 1 to Annual Report on Form10-K/A of ZIOPHARM Oncology, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 30, 2018
/s/ Kevin G. Lafond |
Kevin G. Lafond Senior Vice President Finance, Chief Accounting Officer and Treasurer |
(Principal Financial and Accounting Officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.